Jones Day represented Boehringer Ingelheim Pharmaceuticals, Inc. The U.S. Federal Trade Commission (“FTC”) ended an 11-year investigation into the settlements of two Hatch-Waxman patent infringement lawsuits…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now